Pramlintide and Tirzepatide Therapy for Weight Loss in Diabetes and ESRD: A Bridge to Transplant

被引：0
|
作者：
Chrsitie, Ryan
Richards, Jesse
机构：
来源：
OBESITY | 2024年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Poster-240
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [1] Tirzepatide for weight loss
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (05) : 203 - 203
  • [2] The Role of Pramlintide for Weight Loss
    Dunican, Kaelen C.
    Adams, Nicole M.
    Desilets, Alicia R.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 538 - 545
  • [3] Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?
    Novograd, Joel
    Mullally, Jamie A.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2023, 31 (05) : 278 - 283
  • [4] Tirzepatide highly effective for weight loss
    Tysoe, Olivia
    NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (09) : 520 - 520
  • [5] Tirzepatide highly effective for weight loss
    Olivia Tysoe
    Nature Reviews Endocrinology, 2022, 18 : 520 - 520
  • [6] Semaglutide vs Tirzepatide Dosages for Weight Loss
    Levy, Matthew E.
    Barrett, Kelly M. Schiabor
    Cirulli, Elizabeth T.
    JAMA INTERNAL MEDICINE, 2025, 185 (02)
  • [7] Perspectives on weight control in diabetes-Tirzepatide
    Varkonyi, Tamas T.
    Posa, Aniko
    Pavo, Noemi
    Pavo, Imre
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 202
  • [8] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 416 - 416
  • [9] Tirzepatide-induced weight loss in type 2 diabetes is independent of nausea, vomiting, or diarrhoea
    Patel, H.
    Khunti, K.
    Rodbard, H. W.
    Bajaj, H. S.
    Bray, R.
    Kindracki, Z.
    Rodriguez, A.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S290 - S291
  • [10] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 27 - 28
12345